[go: up one dir, main page]

DE69106388D1 - Antipsychotische 4-(1,2-benzisoazolyl)piperidinderivate. - Google Patents

Antipsychotische 4-(1,2-benzisoazolyl)piperidinderivate.

Info

Publication number
DE69106388D1
DE69106388D1 DE69106388T DE69106388T DE69106388D1 DE 69106388 D1 DE69106388 D1 DE 69106388D1 DE 69106388 T DE69106388 T DE 69106388T DE 69106388 T DE69106388 T DE 69106388T DE 69106388 D1 DE69106388 D1 DE 69106388D1
Authority
DE
Germany
Prior art keywords
benzisoazolyl
antipsychotic
piperidine derivatives
piperidine
benzisoxazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69106388T
Other languages
English (en)
Other versions
DE69106388T2 (de
Inventor
Harry Howard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of DE69106388D1 publication Critical patent/DE69106388D1/de
Application granted granted Critical
Publication of DE69106388T2 publication Critical patent/DE69106388T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE69106388T 1990-11-14 1991-08-16 Antipsychotische 4-(1,2-benzisoazolyl)piperidinderivate. Expired - Fee Related DE69106388T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/612,776 US5147881A (en) 1990-11-14 1990-11-14 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
PCT/US1991/005593 WO1992008718A1 (en) 1990-11-14 1991-08-16 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents

Publications (2)

Publication Number Publication Date
DE69106388D1 true DE69106388D1 (de) 1995-02-09
DE69106388T2 DE69106388T2 (de) 1995-05-04

Family

ID=24454621

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69106388T Expired - Fee Related DE69106388T2 (de) 1990-11-14 1991-08-16 Antipsychotische 4-(1,2-benzisoazolyl)piperidinderivate.

Country Status (10)

Country Link
US (3) US5147881A (de)
EP (1) EP0557289B1 (de)
JP (1) JPH05507281A (de)
AT (1) ATE116316T1 (de)
CA (1) CA2094246A1 (de)
DE (1) DE69106388T2 (de)
FI (1) FI932173A0 (de)
IE (1) IE913940A1 (de)
PT (1) PT99482A (de)
WO (1) WO1992008718A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658823B1 (fr) * 1990-02-27 1992-04-30 Adir Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent .
NZ249286A (en) * 1992-02-13 1996-02-27 Merrell Dow Pharma Piperidine-4-ylmethyl thiophene and thiazole derivatives and pharmaceutical compositions
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
AU690529B2 (en) * 1992-11-23 1998-04-30 Hoechst Marion Roussel, Inc. Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
DK60493D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
WO1998008816A1 (fr) * 1996-08-26 1998-03-05 Meiji Seika Kaisha, Ltd. Derives d'indoxyle et psychotropes
FR2761067B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique
ES2144355B1 (es) * 1997-12-30 2001-01-01 Ferrer Int Compuestos derivados del cromeno.
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
ATE247110T1 (de) * 1999-09-14 2003-08-15 Aventis Pharma Inc Benzisoxazolyl-, pyridoisoxazolyl- und benzthienyl-phenoxy derivate als d4 antagonisten
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
PL375981A1 (en) * 2002-09-17 2005-12-12 Warner-Lambert Company Llc Heterocyclic substituted piperazines for the treatment of schizophrenia
EP1736474A4 (de) * 2004-04-07 2010-04-21 Kyowa Hakko Kirin Co Ltd Piperidinderivat
WO2010012121A1 (zh) * 2008-07-28 2010-02-04 江苏国华投资有限公司 芳烷基哌啶（嗪）衍生物及其在治疗精神分裂症中的应用
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
JP5714152B2 (ja) * 2014-03-26 2015-05-07 江蘇恒誼薬業有限公司 アラルキルピペリジン（又はピペラジン）誘導体及びその統合失調症治療のための使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
JPS5846079A (ja) * 1981-09-12 1983-03-17 Santen Pharmaceut Co Ltd ベンゾチアゾリン環を有するエ−テル類
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
FR2536749A1 (fr) * 1982-11-25 1984-06-01 Cerm Cent Europ Rech Mauvernay (amino-2 ethyl)-6 benzoxazolinones substituees, leur preparation et leurs applications en therapeutique
US4458076A (en) * 1983-05-31 1984-07-03 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidinyl)-1,2-benzisothiazoles
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
GB2176474A (en) * 1985-06-15 1986-12-31 Tanabe Seiyaku Co Thiazolidine derivatives
GB8531666D0 (en) * 1985-12-23 1986-02-05 Wyeth John & Brother Ltd Indole derivatives
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2621588B1 (fr) * 1987-10-08 1991-05-24 Roussel Uclaf Nouveaux derives de la 1,1-dioxo 1,2-benzoisothiazol 3-one, leur procede de preparation et leur application comme medicaments
GB8726763D0 (en) * 1987-11-16 1987-12-23 Fujisawa Pharmaceutical Co Thiazole compounds
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5034392A (en) * 1990-04-16 1991-07-23 Hoechst-Roussel Pharmaceuticals Incorporated 4-(3-(4-oxothiazolidinyl)butynylamines

Also Published As

Publication number Publication date
ATE116316T1 (de) 1995-01-15
FI932173L (fi) 1993-05-13
JPH05507281A (ja) 1993-10-21
FI932173A0 (fi) 1993-05-13
IE913940A1 (en) 1992-05-20
EP0557289A1 (de) 1993-09-01
DE69106388T2 (de) 1995-05-04
CA2094246A1 (en) 1992-05-15
US5385916A (en) 1995-01-31
PT99482A (pt) 1992-09-30
EP0557289B1 (de) 1994-12-28
US5276040A (en) 1994-01-04
US5147881A (en) 1992-09-15
WO1992008718A1 (en) 1992-05-29

Similar Documents

Publication Publication Date Title
ATE116316T1 (de) Antipsychotische 4-(1,2- benzisoazolyl)piperidinderivate.
KR950700290A (ko) 피페라진 및 피레리딘 유도체, 및 이들의 항정신병제로서의 용도(piperazine and piperidine derivatives, and their use as antipsychotics)
DE69332898T2 (de) 4-Carboxamidopiperidinderivate und ihre Verwendung als Neurokinin Antagonisten
MX9201419A (es) Derivados de benzo isoxazol-piperidina.
DE69531331D1 (de) Phenylpiperidinderivate als neurokinin antagonists
MA20323A1 (fr) Nouvelles 4-(heterocycle bicyclique methyle et -hebbero)-piperidines
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
FI913142A0 (fi) Migraenfoerhindrande alkoxipyrimidinderivat.
DE69221919D1 (de) Piperidin-Derivate
ATE129497T1 (de) Bicyclische pyranderivate und ihre verwendung als 5-lipoxygenasehemmer.
BR9206272A (pt) Derivados de 2-(4-hidroxipiperidino)-1-alcanol, como agentes anti-isquêmicos.
FI942635L (fi) Piperatsiinijohdannaiset 5HT1A-antagonisteina
ATE113282T1 (de) Heteroaryl piperazine als antipsychotische mittel.
DE3875159D1 (de) Piperidylaminotriazin-derivate und ihre anwendung als stabilisatoren.
NO984380D0 (no) Nye piperazin og piperidin forbindelser
EE200100498A (et) 1,4-asendatud piperasiin-, 1,4-asendatud piperidiin- ja 1-asendatud 4-alkülidenüülpiperidiinühendidning nende raviotstarbeline kasutamine
ATE196294T1 (de) Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste
ATE178886T1 (de) 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
NO903640D0 (no) Fremgangsmaate for fremstilling av 2-(rs)-substituerte 2,3-dihydro-5-oksy-4,6,7-trimetylbenzofuraner.
BR9606815A (pt) Derivados de piperidina 4-(1H-indolil-1-il)-1-substituídos antipsicóticos
ES2091879T3 (es) Derivados de piperazina.
DE3584652D1 (de) 2,2,6,6-tetramethyl-4-piperidinyl-derivate und ihre verwendung als lichtstabilisatoren.
HU9202914D0 (en) 4-(4-(4-hydroxiphenyl)-1-piperazinyl)-5-methyl-3h-1,2,4-triazole-3-one derivatives
DE69431360D1 (de) N-oxide von 4-arylpiperazinen und 4-arylpiperidinen als antipsychotische medikamente
ATE122886T1 (de) Verwendung von 1,4-dihydropyridin-derivaten in der behandlung von alkoholsucht.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee